At least in the Epm2a–/– model, pathological tau levels are also associated with increased GSK-3β activation (Puri et al., 2009), suggesting that tau hyperphosphorylation is not mediated by the absence of laforin alone in Lafora disease. Here, EPM2A is linked to Lafora disease.